Pure Global
NCT04067141

The Clinical Comparison of Somofilcon A 1 Day and Nelfilcon A Daily Disposable Contact Lenses

The Clinical Comparison of the Clariti 1 Day and DAILIES AquaComfort PLUS Daily Disposable Contact Lenses
Coopervision, Inc.·ClinicalTrials.gov·device·Device trialCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Ametropia
Drug/Device/Intervention
somofilcon A
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Coopervision, Inc.
Location
Manchester, United Kingdom
Timeline & enrollment
Phase
N/A
Start date
Jul 04, 2019
End date
Nov 20, 2019
Enrollment
70 participants
Primary outcome

Subjective Comfort at Lens Dispensing,Subjective Comfort at Start of Day,Subjective Comfort at End of Day,Overall Subjective Comfort,Overall Subjective Comfort,Subjective Vision,Subjective Vision

Summary

This subject-masked, randomized, bilateral crossover study will compare the clinical
 performance and subjective acceptance of the somofilcon A 1 day soft contact lens with the
 nelfilcon A daily disposable lens when used on a daily wear, daily disposable basis.

ICD-10 classifications
Amblyopia ex anopsiaAmoebiasisAmoebiasis, unspecifiedMyoclonusOesophagitis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04067141
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT04067141 through Pure Global AI's free database. This phase not specified trial is sponsored by Coopervision, Inc. and is currently Completed. The study focuses on Ametropia. Target enrollment is 70 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.